Episode 2.6 Covid treatments, IUDs, and management of abnormal HCGs

In this episode, we talk about some updates about Mirena and other IUDs. Then we discuss a new study that looks at the best way to handle pregnancy of unknown location with persistently abnormal HCGs. We discuss new data about the risks of COVID vaccine and miscarriage. Finally, we discuss a variety or claimed and utilized COVID treatments, including Vitamins C and D, Zinc, Azithromycin, Cimetidine, Fenofibrate, Ivermectin, Hydroxychloroquine, Remdesivir, convalescent plasma, monoclonal antibodies, and more. 

Links Discussed:


FDA Label Updates Reflect Bayer’s Commitment to Women’s Healthcare

Efficacy, Safety, and Tolerability of a New Low-Dose Copper and Nitinol Intrauterine Device

Declaring a gestation nonviable: when 99% certainty is not enough

The ACT or NOT Randomized Clinical Trial

Spontaneous Abortion Following COVID-19 Vaccination During Pregnancy

Effect of High-Dose Zinc and Ascorbic Acid Supplementation vs Usual Care on Symptom Length and Reduction Among Ambulatory Patients With SARS-CoV-2 Infection: The COVID A to Z Randomized Clinical Trial

Ivermectin isn’t a highly effective drug for treating COVID-19